Human beings live in an environment of competing risks of death any of which may terminate life at any age. However, these risks vary considerably in their intensity through life. There are two types of indicators widely used in quantifying premature deaths due to a particular disease. One is the potential gain in life expectancy (PGLE) 2, 3 and the other is the years of potential life lost (YPLL). [4] [5] [6] [7] The PGLE, by the elimination of deaths from a particular cause, is the added years of life expectancy for the population if the deaths from that cause were removed or eliminated as a competing risk of death. This type of measurement is based on multiple-decrement life table techniques that properly take into account competing risks of death and the age structure of the population. The YPLL is the 'years of life lost' by those individuals that died. It is a weighted sum of number of deaths from a particular disease under the concerned period of life span. 1 This type of method fails to take into account competing risks and is heavily influenced by population age structures. Our study compared both types of measurements on the US population of working age (15-64 years) in 1987-1992 by race-gender.
Methods and Materials
Using the multiple-decrement life table technique 3, 8 and the monthly vital statistics report, 9 together with more detailed data provided by the National Center for Health Statistics, we computed the life expectancy due to elimination of death from diseases of the heart (ICD-9 390-398, 402, 404-429), malignant neoplasms (ICD-9 140-208) and HIV/AIDS (ICD-9 042-044). The results were computed for the race-gender specific working population (15-64 years) in the US during 1987-1992.
The PGLE in those of working age, by elimination of a particular cause of death, are the added years of the life expectancy beyond age 15. The mortality intensity from other causes remains unchanged. 2, 3 This method, in measuring the impact of a disease, takes into account the competing risks that the concerned cohort would face had a particular cause of death been eliminated. The added years of life for working ages are those added years that one can expect to gain between 15 and 64 years old before reaching the end of the working range at age 65. It is the expected years gained for an individual in the age 15 cohort. In order to construct the multiple-decrement life table to determine the PGLE, one first calculates the net probability of dying from cause k if cause k is eliminated as a competing risk. The net probability of dying from cause k is given by the following formula:
where k = 1,2,…r, p i is the probability of surviving age interval (x i , x i+1 ), D i is the total number of deaths in age interval (x i , x i +1 ), and D ik is the number of deaths from cause k in age interval (x i , x i+1 ). More detailed discussions of the methodology are provided by Chiang (p.257). 8, 10 To compute the YPLL for the US race-gender specific population of working age due to a cause of death, we sum the weighted number of deaths from that cause. There are many ways of weighting the number of deaths due to a particular cause. 1 The most commonly used form for the years of the YPLL is
where d i is the number of deaths from the cause under concern in the ith age group and a i is the remaining years the individuals would have had if they had not died prematurely. Usually, a i = l -m i , where l is the upper age limit and m i is the mean age for age group i. For the working population, we let l be 65. The YPLL purports to measure the years lost due to the particular cause of death being eliminated. However, it is well known that YPLL does not properly take into account competing risks because if one does die from cause j, he or she may die from cause k later before reaching the upper limit l. 6 Although YPLL is not a good measurement of the impact of a disease on a population, in practice, the YPLL is widely used for this purpose. [4] [5] [6] [7] The PGLE and the YPLL were computed for deaths from HIV/AIDS, diseases of the heart and malignant neoplasms for the US population of working age by race and gender groups in 1987-1992. The PGLE is an average for individuals in the population and the YPLL is a total years added for a study population. 1, 2 In order to make these two methods comparable numerically, we converted the average gains in life expectancy for an individual into the total PGLE for the US population in working ages by multiplying gains in life expectancy with the number of people in the cohort at the corresponding age 15 cohort to give the gains of the future years lived by the cohort in working ages. 11, 12 The value of the YPLL is heavily influenced by the age structure among different populations. Direct method of standardization on YPLL was proposed to stabilize the value of the YPLL across various studied populations. 13 The YPLL in this paper is computed based on the standardized version. The race-gender specific population from the US 1990 census was used as the standard population. 14 
Results
The total PGLE and the standardized YPLL for the US white males in working ages in 1987-1992 are plotted in Figure 1 Figure 1 , the impact of the HIV/AIDS for black females of working age increased faster than that of white females of working age and slower than that of white males of working age during 1987-1992. For the above three race-gender groups, the impact of HIV/AIDS was less than that of diseases of the heart and malignant neoplasms, however, in Figure 2 (a) and Figure 2(b) , for black males of working age, the impact of HIV/AIDS increased dramatically. For the PGLE, the impact of HIV/AIDS overtook the impact of malignant neoplasms, but it showed less impact than diseases of the heart in 1992. However, the YPLL due to HIV/AIDS was larger than that of malignant neoplasms in 1989 and it surpassed the impact of diseases of the heart and malignant neoplasms in 1991 and 1992.
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To compare the effect of these two methods within a particular cause of death, we computed the relative ratios presented in Tables 1-3 . The YPLL for HIV/AIDS usually overestimated the impact of the disease when compared to the total PGLE. For the total and white population of working age, the YPLL were about 20-30% higher than the PGLE. If the non-standardized version of YPLL was compared to the PGLE, we observed similar overestimation although they were less consistent (the numerical results are not shown here). For the US black population of working age, the values from these two methods gave similar results. Table 2 and Table 3 indicate that the YPLL generally underestimated the impact of diseases of the heart and malignant neoplasms when compared to the total PGLE. For the US black population of working age, it was an underestimate of about 20-30%, but for the total population and the white population of working age, the relative differences between the YPLL and the total PGLE were much smaller than that for the black population of working age.
The patterns of inconsistency of these two methods were similar for diseases of the heart and malignant neoplasms in measuring the impact of premature deaths since the deaths among working age people from both these causes tend to appear in the later part of life. HIV/AIDS, on other hand, showed a different pattern of inconsistency because deaths from HIV/ AIDS occurred relatively early.
Discussion
Mathematically, the PGLE and the YPLL measure different things. The PGLE measures the impact of a cause or causes of death incorporating competing risks into a mathematical model for the survival experience of individuals in the population. It anticipated what would happen to a cohort of individuals if particular causes of deaths could be removed. The YPLL is a weighted average of deaths that occurred in a population without taking into account the competing risks. 1,2 It is not surprising that these two methods differ in their numerical results. However, both methods are used in assessing relative impact of a cause of death on a population.
The comparative studies indicated that the YPLL does not always provide similar or even consistent results to those obtained from the PGLE. By the nature of the measurement of the YPLL, the comparisons of the YPLL across populations can be influenced by the age structure of the populations. To improve the comparability across populations, standardization techniques were proposed. 1, 13 Conti et al. 13 used the standardized YPLL rate in measuring the impact of HIV/AIDS on the population of Italy. Using the 1990 census data, we compared the YPLL with the total PGLE for the US working population by race and gender for 1987-1992. The numerical values of the YPLL without standardization are more variable than those with standardization, but inconsistencies with the PGLE remain. The detailed numerical results for the comparisons using the non-standardized version are available upon request from the authors.
A recent article addressed the issue of how to account for competing risks of death and obtain a more appropriate measure of YPLL. 15 The approach was to simply modify the standard measures of YPLL. The measure proposed was not based on a IMPACT OF COMPETING RISKS OF DEATH 897 a The values in the table were 100(y/x -1), where x is the years of the potential gains in life expectancy for working ages (15-64) by eliminating HIV/AIDS deaths using the number of people at age 15 from the 1990 census of the US as the standard cohort and y is the years of potential life lost due to HIV/AIDS deaths using the total number of people of working age (15-64) from the 1990 census of the US as the standard population. by eliminating diseases of the heart deaths using the number of people at age 15 from the 1990 census of the US as the standard cohort and y is the years of potential life lost due to diseases of the heart deaths using the total number of people of working age (15-64) from the 1990 census of the US as the standard population. The PGLE based on multiple-decrement life table technique uses the schedule of age-specific and cause-specific death rates to account for the impact that a cause of death is having on the average future lifetime of individuals in the population. The multiple-decrement technique used here assumes that individuals in the population are subject to a number of independent competing causes of death acting simultaneously on the population. Methods involving dependent competing risks are often complex, and some empirical results indicate that the effect of deaths from malignant neoplasms for the purpose of statistical analysis may be treated as independent of HIV/AIDS. 10 Therefore, for simplicity, we continued to use the assumption of independent competing risks in constructing the multiple-decrement life table in our study as has been described elsewhere. 3 Calculation of PGLE is simple and within the limitations of the model one can effectively account for the impact of competing risks on a population. They are easily modified to allow for partial elimination of competing risks. 2 In some instances the vital statistics information needed to calculate PGLE may be unavailable and YPLL will be the only recourse. However, in these cases one must remember that the years of potential life lost indicated by the YPLL are not really lost, but merely obscured by the inability of the chosen measure to account adequately for competing causes of death. For these reasons, the PGLE is preferable to the YPLL and its variations as well as the measure proposed by Lee. 15 
